NCT01595529 - "The SCOUT Study: Short Course Therapy for Urinary Tract Infections in Children" | Biotech Hunter

Enrollment

717

Participants

Timeline

Start Date

May 18, 2012

Primary Completion Date

June 30, 2019

Study Completion Date

August 12, 2019

Conditions

Urinary Tract Infection

Interventions

DRUG

Cefixime

Cefixime 8 mg/kg/day orally, in 1 dose, with a maximum of 400 mg. Subjects originally receiving Cefdinir will receive Cefixime.

DRUG

Cephalexin

Cephalexin 50mg/kg/day in 3 divided doses

OTHER

Placebo

Placebo to match the other four active treatments

DRUG

Trimethoprim/Sulfamethoxazole

8 mg/kg/day of Trimethoprim-sulfamethoxazole (TMP-SMX) orally in 2 divided doses, with a maximum dose of 160 mg twice a day.

Trial Locations (1)

Children's Hospital of Pittsburgh of UPMC - General Academic Pediatric, Pittsburgh

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH